Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GlutaGenic appears to have been a small U.S.-based health and wellness company associated with Advanced Biome Corp and marketed supplement-style products rather than a traditional therapeutic drug pipeline. Publicly available evidence links the brand to Sarasota, Florida and to websites glutagenic.com and advancedbiomecorp.com, which in 2020 received FDA and FTC warning letters over unlawful COVID-19-related marketing claims for "Viral Protection Kits." Available third-party references suggest the business promoted products involving glutathione, melatonin, probiotics, and related wellness formulations. I found no credible evidence of a conventional biotech or pharmaceutical development pipeline, clinical-stage assets, or regulatory-approved therapeutics. The company appears best categorized as a wellness/nutraceutical brand with limited verified corporate disclosure and uncertain current operating status.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GlutaGenic.